Having trouble accessing articles? Reset your cache.

Sunesis brings in $15.4M to fund leukemia study

Sunesis Pharmaceuticals Inc. (NASDAQ:SNSS) raised $15.4 million through the

Read the full 93 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE